Effects of short-term therapy with glibenclamide and repaglinide on incretin hormones and oxidative damage associated with postprandial hyperglycaemia in people with type 2 diabetes mellitus - Jeffrey Stephens (Diabetes Research and Clinical Practice, 2011)